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ABSTRACT
Characterization of the epigenetic status of individ-
ual cells remains a challenge. Current sequencing
approaches have limited coverage, and it is difficult
to assign an epigenetic status to the transcription
state of individual gene alleles in the same cell. To
address these limitations, a targeted microscopy-
based epigenetic visualization assay (EVA) was de-
veloped for detection and quantification of epige-
netic marks at genes of interest in single cells.
The assay is based on an in situ biochemical reac-
tion between an antibody-conjugated alkaline phos-
phatase bound to the epigenetic mark of interest, and
a 5′-phosphorylated fluorophore-labeled DNA oligo
tethered to a target gene by gene-specific oligonu-
cleotides. When the epigenetic mark is present at the
gene, phosphate group removal by the phosphatase
protects the oligo from -exonuclease activity pro-
viding a quantitative fluorescent readout. We applied
EVA to measure 5-methylcytosine (5mC) and H3K9Ac
levels at different genes and the HIV-1 provirus in hu-
man cell lines. To link epigenetic marks to gene tran-
scription, EVA was combined with RNA-FISH. Higher
5mC levels at the silenced compared to transcribed
XIST gene alleles in female somatic cells validated
this approach and demonstrated that EVA can be
used to relate epigenetic marks to the transcription
status of individual gene alleles.
GRAPHICAL ABSTRACT
INTRODUCTION
Epigenetic programs specify cell phenotypes through cova-
lent modifications of histones and DNA, nucleosome posi-
tion and density, and substitution by histone variants (1–
3). While epigenetic alterations drive normal organism de-
velopment, aberrations in these processes have emerged as
hallmarks of cancer and other diseases where particular
cell types and individual cells may play critical roles. Con-
ventional approaches used to study epigenetic events, such
as chromatin immunoprecipitation (ChIP) and bisulfite se-
quencing (BS-seq), measure averaged gene epigenetic states
in bulk cell populations or tissue fragments and can there-
fore not be used to estimate the contribution of individual
cells to the epigenetic profile of a specimen, let alone com-
bined epigenetic and transcription analysis of gene alleles in
a single cell.
To assess epigenetic states in individual cells, sequencing-
based and imaging-based techniques have recently been
introduced for single cell epigenetic analyses (4). A
microscopy-based approach has been developed to measure
histone modifications at individual genes in single cells us-
ing a proximity ligation assay (ISH-PLA (5)). The advan-
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tage of ISH-PLA is that it works in situ. However, it involves
two enzymatic steps (ligation and rolling circle replica-
tion) that yield qualitative rather than quantitative results.
Also, the approach only works in a small fraction of cells
(<1%). Most of other epigenetic approaches are focused
on genome-wide DNA methylation measurements as these
have higher sensitivity compared to histone modification
analytical tools. DNA methylation is described as the addi-
tion of a methyl group at the C-5 position of cytosine (5mC)
mostly in CpG dinucleotides. There are 28 million CpGs in
the human genome and most of them are methylated in so-
matic cells (6–8). Locus-specific DNA methylation can be
involved in gene silencing, which is an important event in
processes such as cell differentiation, X-chromosome inac-
tivation, genomic imprinting, and suppression of repeat se-
quences (2,9–16). Across the genome, the level of methy-
lation is considered to be inversely correlated with CpG
density (17,18). Hypermethylation of dense CpG clusters,
called CpG-Islands (CGIs), near promoter regions of mam-
malian genes is related to transcriptional silencing (9,19–
23). CGI methylation status follows a bimodal distribution,
where most of islands are either hypo- or hyper-methylated
(18). Less studied methylation of sparse intragenic CpGs
is most likely involved in the regulation of cryptic intra-
genic promoters, alternative splicing and cellular differen-
tiation (24–28). Generally, levels of intragenic methylation
positively correlate with gene transcription rates.
Low sequencing coverage and resolution remain the
key limitations of sequencing-based DNA methylation and
histone modification analyses in a single cell (4). Also,
these approaches cannot be used to assign epigenomic
sequencing data to individual gene alleles in a cell, and
more importantly, to the gene transcription status. Another
caveat is their limited applicability to the analysis of rare
genomic/epigenomic events, such as HIV-1-infected cells
present at frequencies 10−4 or lower in infected patients.
As a consequence, very large numbers of cells need to be
sequenced to allow detection of rare events. To enable si-
multaneous analysis of epigenetic and transcription states
of genes of interest in single cells, we developed a novel Epi-
genetic Visualization Assay (EVA). This method is based
on an in situ proximity reaction that generates fluorescent
signal proportional to the density of an epigenetic mark as
DNA methylation or histone modifications at the gene of
interest. EVA was tested and validated to quantitate levels
of DNA methylation of several target genes in single cells.
Combining EVA with RNA FISH enables the simultaneous
analysis of DNA methylation and RNA transcription levels




J-Lat clones 8.4 and 9.2 from Dr Verdin laboratory were ob-
tained through the NIH AIDS Reagent Program, Division
of AIDS, NIAID, NIH (29). HEK-293 and HUVEC cells
were grown in DMEM, 10% FBS; Jurkat and J-Lat cells
were grown in RPMI1640, 10% FBS. Serum starvation was
performed by incubating cells overnight in RPMI1640 sup-
plemented with 0.1% FBS. Serum starved cells were treated
with 12-O-Tetradecanoylphorbol-13-acetate (TPA, 50 nM)
for indicated periods of time, then chilled on ice, washed
once with ice cold PBS, and either fixed with cold methacarn
solution, or dissolved in Trizol for RNA/DNA isolation.
Genomic qPCR and reverse transcription qPCR (RT-qPCR)
RNA was isolated using TRIzol reagent (Invitrogen) ac-
cording to the standard protocol. After cleaning with
DNAse I (1 U/10 g DNA in 20 l final volume, 15 min
at room temperature (RT)) (D9905K, Epicentre/Lucigen),
1 g of RNA was reverse transcribed with SuperScript IV
Reverse Transcriptase (4 U/l, # 18080093, ThermoFisher)
in a 10 l reaction, 45 min at 37◦C. After reverse transcrip-
tion, cDNA was diluted 100-fold with TE, boiled for 5 min,
chilled on ice and quantified using qPCR with primers tar-
geting specific genes of interest (primer sequences are shown
in Supplemental Table S1). PCR was performed in tripli-
cates using an in-house qPCR mix. 2 ng cDNA was added
to 2.5 l of in-house 2× qPCR mix containing SYBR Green
and 500 nM forward and reverse primers, in a final vol-
ume of 5 l. Amplification (three steps, 40 cycles), data ac-
quisition and analysis were carried out using the 7900HT
Real Time PCR system and SDS Enterprise Database soft-
ware (Applied Biosystems). Standard dilutions of genomic
DNA (for genomic targets) or dilutions of pooled reverse
transcription reactions (for cDNA targets) were included in
each PCR run. Transcript levels were normalized to both
LAMC1 and ribosomal protein RPL32 mRNAs, on which
the effect of TPA is minimal.
Probe design
EVA oligo probes for human genes were designed us-
ing sequences obtained from the assembly GRCh38/hg38,
UCSC genome browser (https://genome.ucsc.edu/cgi-bin/
hgGateway). We filtered out repeats and regions with sim-
ilarity to other genomic sites and designed 50–96 perfect
matching oligo probes (30-mers) with spaces between them
of ∼20 bp, so that the probe mix covers a genomic region
up to 5 kb. All oligos had the same 3′ common sequence
(TAG TTT CAG CTT TCC GCA AC) attached, to be used
for signal detection. A list of gene-specific oligos is available
upon request. Probes for the HIV target were designed sim-
ilarly, using a reference HIV-1 genome consensus sequence
derived by alignment of all complete HIV genomes available
in the database from the Los Alamos National Laboratory
website (www.hiv.lanl.gov). Oligonucleotides were synthe-
sized by Eurofins Genomics.
5mC EVA
EVA detection/signal amplification oligonucleotides (Sup-
plemental Table S1) were HPLC-purified and dissolved in
water at 100 M. Formamide (deionized) was from EMD
Millipore Corp., S4117; Dextran Sulfate was from Amer-
sham Pharmacia Biotech, #17-0340-01.
Day 1: hybridization. Cells were placed on ice, collected
by centrifugation, washed once with cold PBS (20 mM K-
phosphate pH 7.2, 150 mM NaCl), and the pellet was re-
suspended in 1 ml of cold methacarn fixative (three parts of
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methanol mixed with one part of glacial acetic acid), stored
at –80◦C. For specimen preparation, 10 l of cell suspen-
sion in methacarn was dropped on a 22 × 22 mm cover slip
and allowed to spread. After air drying, cover slips were in-
cubated at 65◦C for 10 min, then cooled to RT. 10 l of hy-
bridization solution (2× SSC, 50% formamide, 10% dextran
sulfate, 1% Tween-20, oligo mix (100 nM each)) was pipet-
ted on a glass slide, cover slips (cells down) were placed on
top and sealed with rubber cement. Slides were incubated
at 95◦C for 3 min, transferred to a humidified Petri dish (10
cm), and incubated at 37◦C overnight.
Day 2: signal amplification and alkaline phosphatase
(AP) treatment. Slides were covered by PBS, rubber ce-
ment was removed, and coverslips were transferred to a
Petri dish with 10 ml of wash solution (2xSSC, 50% for-
mamide, 0.1% Tween-20), and shaken for 30 min at RT.
After washing four times with TBST (10 mM Tris–HCl
pH 7.5, 150 mM NaCl, 0.1% Tween-20), coverslips were
incubated with 10 ml blocking buffer (5% BSA in TBST)
for 30 min at RT. 100 l of blocking buffer with 1:200
anti-5mC monoclonal antibody (clone 33D3, AMM99021,
Aviva Systems Biology) and 150 nM CCB oligo solution
was pipetted on a piece of parafilm in a humidified Petri
dish, coverslips were placed on the drop (cells down), and
incubated for 30 min at RT. After 3 × 5 min washes with
TBST, cover slips were incubated with 100 l of 150 nM
DAA/TBST for 30 min, washed with TBST 3 × 5 min,
incubated in 100 l TBST with 1:300 AP-anti-mouse an-
tibody (AP-2000, Vector Labs) and 150 nM CCB/TBST
for 30 min, washed with TBST 3 × 5 min, incubated with
100 l of 150 nM DAA/TBST for 30 min, washed with
TBST 3 × 5 min. Then coverslips were incubated with 100
l of 150 nM RF42/TBST with phosphatase inhibitors (PI,
p-nitrophenyl phosphate 30 mM, -glycerophosphate 10
mM, NaF 10 mM, Na3VO4 0.1 mM, Na2MoO4 0.1 mM)
for 30 min, washed with TBST/PI 3 × 5 min, rinsed once
with TBST and once with AP buffer (50 mM Tris–HCl
pH 8.8, 100 mM NaCl, 2.5 mM MgCl2), and incubated in
AP buffer overnight at RT in the dark.
Day 3: exonuclease treatment. Cover slips were washed
with TBST 3 × 5 min, incubated with 100 l of 150 nM DF
for 30 min, washed 3 × 5 min with TBST, rinsed with AP
buffer, incubate with  exonuclease (M0262S, New England
Biolabs) (45 l H2O, 5 l 10× buffer, 10 U exonuclease per
coverslip) for 1.5 h at RT, washed 3 × 10 min with TBST,
rinsed with Tris–HCl 50 mM pH 7.5 with or without DAPI,
mounted in 8 l Vectashield (H-1000, Vector Labs) on a
slide and sealed with colorless nail polish. Slides were stored
at 4◦C in the dark.
RNA FISH
10 l of cell suspension in methacarn were dropped on 22 ×
22 mm cover slip and spread. After drying, cover slips were
incubated at 65◦C for 10 min, then allowed to cool to RT.
10 l of hybe solution (2× SSC, 50% formamide, 10% dex-
tran sulfate, 1% Tween-20, oligo mix (48 oligos to RNA of
interest, 100 nM each)) was dropped on a glass slide, cover
slips (cells down) were placed on top and sealed with rubber
cement. After air drying, slides were transferred to a humid-
ified Petri dish and incubated at 37◦C overnight.
For tyramide signal amplification (TSA), coverslips were
washed once for 30 min in hybe washing solution at RT,
rinsed four times with TBST, incubated with 100 l of 150
nM RN1-Bio for 30 min, washed 3 × 5 min with TBST,
rinsed once with 4× SSC 0.1% Tween 20, incubated with
100 l of Avidin-HRP conjugate (A106, Leinco Technolo-
gies) in 4× SSCT (1:300 dilution) for 45 min. After three
washes in 4× SSCT and one in TBST, coverslips were in-
cubated in 100 l of 100 mM Na-borate pH 8.5, 0.5 mM
H2O2, 1 g/ml biotin-xx-tyramide (#92176, Biotium) (0.1
g/ml for rRNA ETS probe) for 30 min at RT. After TBST
washes, coverslips were incubated in 100 l of streptavidin
conjugated to desired fluorophore, washed and mounted in
Vectashield with or without DAPI.
RNA FISH + EVA
To combine RNA FISH with EVA, coverslips after biotin-
tyramide TSA reaction were incubated in hybridization
washing solution for 1 h at RT, excess of solution was
drained on paper towel, coverslips were placed on 10 l
of hybridization solution containing EVA oligo mix on a
slide, sealed with rubber cement, and processed according
to the EVA protocol as described above. Biotin was visual-
ized using rabbit anti-biotin antibodies (1:300, A150-109A,
Bethyl) and goat anti-rabbit Alexa Fluor 405 IgGs (1:300,
A31556, Thermo Fisher).
H3K9Ac EVA
Cells attached to coverslips were fixed with ice-cold 70%
ethanol and were stored in the same solution at 4◦C be-
fore use. Coverslips were consecutively rinsed in 80%, and
100% ethanol, then dried. To suppress endogenous perox-
idase activity, coverslips were incubated in 0.3% H2O2 in
methanol for 30 min, then airdried. After rehydration in
PBS, coverslips were incubated in blocking solution (3%
BSA in TBST) for 30 min, then H3K9Ac rabbit monoclonal
antibodies (#9649, Cell Signaling) diluted 1:500 in block-
ing solution were added for 45 min followed by 3 × 5 min
washes in TBST. Goat anti-rabbit HRP-conjugated IgGs
(T20925, Invitrogen) were added (1:300 dilution in TBST)
for 45 min followed by 3 × 5 min washes in TBST. TSA re-
action was performed with biotin-xx-tyramide as described
in RNA FISH section. Coverslips were dehydrated in 70%,
80%, 100% ethanol, dried and used in EVA as described
above.
Image analysis
Images were collected using a Zeiss Axiovert 200M micro-
scope with Plan-Neofluar 100×/1.3 oil objective. The im-
ages were analyzed in Fiji image analysis freeware (30) using
a dedicated image analysis script (LociDetector.ijm, avail-
able upon request). The analysis essentially detects individ-
ual fluorescent signals (loci) within single nuclei and calcu-
lates for each locus the ratio of signal intensities between
two channels (markers), one reference or detector channel
and a second measurement or sensor channel. First, the
smoothened background signal of the reference channel is
used to segment the nucleus. Then, loci are segmented in
e43 Nucleic Acids Research, 2021, Vol. 49, No. 8 PAGE 4 OF 9
both channels using a Laplacian spot detector. Per locus, a
concentric band of 5 pixels (rim) is generated, which is used
to correct for local intensity variations in the background
signal. Then, the signal intensity is measured for each locus
and corresponding rim per channel, and the ratio of the cor-
rected intensities is calculated as follows: G/R = [ILocus Ch2 –
IRim Ch2]/[ILocus Ch1 – IRim Ch1], with Ch1 the detector (refer-
ence) channel and Ch2 the sensor channel. Before analysis,
images were registered by translation to correct for chro-
matic shift.
BrdU staining
To detect replicating cells, 10 M BrdU (5-bromo-2′-
deoxyuridine) was added to the culture medium of serum
starved Jurkat cells (0.1% FBS overnight) for 0.5, 4 or 5.5
h (31) (a fraction of BrdU-negative cells that replicated
EGR1 locus is expected to decrease with increased incu-
bation time). For the last 5 min of BrdU treatment, serum
was added to 10% to induce EGR1 gene (for subsequent
RNA FISH assays). Cells were chilled on ice, washed in
cold PBS, fixed in ice-cold methacarn and stored at –80◦C.
10 l of cell suspension in methacarn was pipetted onto
a 22 × 22 mm cover slip and spread. After drying, cover
slips were incubated at 65◦C for 10 min and cooled to RT.
RNA FISH was done with EGR1 oligo mix probe as de-
scribed above using TSA and biotin-xx-tyramide. Cells were
incubated in 1 M HCl for 20 min at RT, neutralized in 0.1
M sodium phosphate buffer pH 7.4, washed three times in
PBS and stained with UltraAvidin DyLight 594 at 1:500 di-
lution (A427, Leinco Technologies) and rabbit anti-BrdU
antibody at 1:500 dilution (#600-401-C29, Rockland) fol-
lowed by fluorescein-conjugated goat anti-rabbit IgG (FI-
1000, Vector Labs). Specimens were counterstained with
DAPI and mounted in antifade solution on slides. The num-
ber of EGR1 RNA foci (red) per nucleus was recorded for
BrdU-positive (green) and negative cells.
MeDIP
5mC antibodies (mouse clone 33D3, AMM99021, Aviva
Systems Biology) used in MeDIP bind to 5mC in a single
stranded DNA, thus, before immuno-precipitation, DNA
from cells was sheared to small fragments (∼300 bp) by ul-
trasound and melted by boiling. 1 g of DNA purified from
cells was diluted to 0.5 ml with TE buffer, treated with ul-
trasound for 30 s (Bronson sonifier, equipped with a mi-
crotip), precipitated with ethanol, washed once with 70%
ethanol, dried, and dissolved in 10 l of TE buffer. Be-
fore immunoprecipitation (IP), DNA samples were boiled
for 5 min, and chilled on ice. 0.5 g of DNA was used in
one IP reaction. MeDIP was done in 96-well plates as de-
scribed (32,33). Monoclonal antibodies to 5mC, 0.3 g per
IP reaction, were used. Mock IP was done without added
antibodies. qPCR analysis of precipitated DNA was done
with gene-specific primers as described above. 10% of the
amount of input DNA used in IPs was analyzed in parallel
by qPCR to estimate efficiency of IP. PCR reactions were
run in triplicate. Standard dilutions of genomic DNA were
included in each PCR run. Sequences of primers used are
in Supplemental Table S1.
FACS sorting
J-Lat 8.4 cells were latently infected with an HIV-1 defective
pseudovirus encoding GFP (26). Cells were either untreated
or treated with TPA for 8hrs, chilled on ice, washed with
cold PBS, and kept on ice before sorting. FACS Aria II cell
sorter (BD Biosciences) was used to sort GFP+ and GFP−
J-Lat 8.4 cells. Singlets were selected by forward versus side
scatter profiles.
Statistical analysis
An estimated minimum sample size to detect 1.5-fold dif-
ference between two samples (for standard deviation 0.5,
power 0.8,  0.05) was 16. To measure differential methy-
lation, EVA signal ratios of at least 25 cells per specimen
were analyzed as G/R as described above. These ratios were
normalized using the average G/R of the negative controls
(cells treated without -exonuclease). Wilcoxon rank-sum
test was used to calculate P values.
RESULTS AND DISCUSSION
Epigenetic visualization assay
EVA is based on an in situ proximity reaction where de-
tector (red) and sensor (green) oligonucleotides are both
tethered to a gene of interest via gene-specific (30nt) oligos
with common (20nt) 3′ sequence (graphical abstract). The
assay takes advantage of the ability of 5′-3′ -exonuclease
to selectively degrade 5′-phosphorylated strands of double-
stranded DNA, as opposed to un-phosphorylated strands
or single-stranded DNA. -exonuclease activity in the assay
is controlled by an alkaline phosphatase (AP) recruited as
an antibody conjugate to the epigenetic mark of interest. In
absence of AP (no epigenetic mark at the gene of interest),
the probe remains phosphorylated at its 5′ end, causing the
-exonuclease to degrade the 5′ half of the detector oligo up
to the nick region, thereby releasing the sensor oligo. This
results in a low sensor/detector (green/red in graphical ab-
stract) fluorescent signal ratio (G/R). In the presence of AP
(epigenetic mark at the gene of interest), 5′-phosphate is re-
moved, protecting the detector oligo from the -exonuclease
and thus retaining both signals at the locus of interest. This
event is detected as a high sensor/detector signal ratio G/R.
By virtue of the internal signal normalization, the assay thus
allows for quantitative analysis of epigenetic marker density
at selected genomic sites.
To test the design, we began with the detection of DNA
methylation (5-methylcytosine, 5mC) at ribosomal DNA
loci, which have, due to the multiple copies of rDNA in
mammalian genomes, low sensitivity requirements. It has
been estimated that about half of rDNA loci are methy-
lated in mammalian cells (34). As a probe we designed a
series of 50 oligonucleotides that cover 2.5 kb of 5′ ETS
of the human rDNA gene (shown as green line in Figure
1A). This probe was hybridized to fixed human HEK-293
cells overnight. After incubation with 5mC primary and
AP-conjugated secondary antibodies followed by washes,
detector and sensor oligos were added in the presence of
phosphatase inhibitors to block the reaction between the
bound AP and detector oligo in solution. Specimens treated
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Figure 1. RNA FISH––EVA analysis of rDNA locus. (A) rDNA transcrip-
tion unit and probe design. EVA probe (green) consisted of 50 oligos that
cover 2.5kb of the 5′ External Transcribed Spacer (5′ ETS). RNA probe
(blue) was to the opposite strand of the same region of 5′ ETS. (B) Repre-
sentative images of rDNA EVA performed in HEK293 cells showing sig-
nals in red (rDNA), green (5mC), and blue (rRNA ETS) channels. The
upper panel shows RNA-EVA images (5mC Ab), the lower panel shows
no-antibody control images (no Ab). Projections of z-stack images of rep-
resentative cells are shown. Scale bar 5 m.
without 5mC antibody were used as a control. There are
five chromosome arms in human cells that contain rDNA
gene clusters (50–80 gene copies per cluster), therefore we
expected to see maximum ∼15 foci per cell in HEK-293 cells
(hypotriploids with modal chromosome number 64) if they
were not clustered. We observed on average ten rDNA foci
of diverse sizes per nucleus and all of them also contained
the sensor green signal, which reflects the presence of methy-
lated CpGs at the locus (Figure 1B). This was further sup-
ported by the absence of detectable green signal at red foci
in control cells treated without 5mC antibodies. No differ-
ence in green signal intensity was seen between rDNA loci
co-localized with 5′ ETS rRNA transcript (blue in Figure
1B) versus those that were not co-localized, suggesting that
either the methylation of 5′ ETS region is not related to the
gene transcription status, or that active (unmethylated) and
silenced (methylated) rDNA repeats are co-clustered in hu-
man cells (35).
XIST EVA
As the methylation status of rDNA copies within and be-
tween rDNA clusters is poorly understood, it is difficult
to confirm the specificity of the green signal as a readout
for 5mC at the rDNA locus by other methods. Therefore,
to validate EVA, we subsequently analyzed a gene with
known differential distribution of DNA methylation be-
tween the silenced and expressed alleles, XIST. In human fe-
male somatic cells, the XIST gene located on the inactive X
chromosome (Xi), is transcribed and its promoter is hypo-
methylated, whereas its copy on the active X chromosome
(Xa) is silenced and hyper-methylated (36,37). Non-coding
XIST transcript binds to Xi and participates in its inacti-
vation (38,39). Thus, experimentally, Xi can be visualized
by XIST RNA FISH (38). Therefore, we set out to perform
Figure 2. Imprinted XIST gene. (A) Human XIST gene locus and probe
design. Gray boxes – exons, white box – intron. EVA probe (green) con-
sisted of 85 oligos that cover the ∼4.5 kb which include gene promoter and
the beginning of exon 1. RNA probe (blue) was designed to recognize the
end of exon 1. (B) Representative image of XIST RNA-EVA performed in
human female HUVEC. The upper panel shows RNA-EVA images (5mC
Ab, EVA), the lower panel shows a no  exonuclease control (No ). Ar-
rows point to XIST DNA foci (red). Scale bar, 5 m. (C) Quantitative
analysis of images. To measure 5mC density at XIST loci, green and red
signals were background corrected, and green-to-red signal intensity ratios
were taken for XIST RNA-positive (RNA+) and negative (RNA−) foci.
The ratio of 5mC signal at RNA– to RNA+ foci in each cell was calculated.
Each dot shown in the graph represents one cell, P < 0.05, n = 20.
combined XIST RNA–5mC EVA assay in human cells. We
used an EVA probe to a ∼4.5 kb region including the gene
promoter and part of the first exon. The XIST RNA FISH
probe consisted of a mix of oligos to the end of exon 1 (both
probes are shown in Figure 2A). In test experiments, DNA
FISH signal obtained with XIST EVA probe in HUVEC
cells was very weak in some cells and undetectable in oth-
ers. To make this signal detectable in the majority (>80%)
of cells, we introduced a branched oligo-based signal ampli-
fication step (Supplemental file, Figure S1).
Combined XIST RNA-EVA assay in human female cell
line HUVEC (Figure 2) showed a 2-fold lower DNA methy-
lation signal at the XIST RNA (+) locus compared to the
RNA (−) locus (P <0.05) (Figure 2B, upper panel, and C).
In control cells without -exonuclease treatment, green sig-
nal was equal at both the RNA-positive and -negative XIST
foci (Figure 2B, lower panel), and green signal was unde-
tectable in cells treated without 5mC antibody (not shown).
These observations provide further support to the interpre-
tation that the green signal quantitatively reflects the density
of 5mC at the locus (Figure 2C). Some cells had more than
two XIST EVA signals per nucleus, most likely due to DNA
replication. These cells were excluded from the analysis. We
also noted substantial cell-to-cell variation in the 5mC ratio
between XIST alleles, suggesting a diversity in methylation
patterns.
EGR1 EVA
Having confirmed that EVA returns a quantitative read-
out on methylation status, we next applied EVA to exam-
ine EGR1, a gene of which the expression can be induced
e43 Nucleic Acids Research, 2021, Vol. 49, No. 8 PAGE 6 OF 9
Figure 3. Single copy EGR1 gene. (A) Human EGR1 gene locus and probe
design. Grey boxes are exons, white box is intron. EVA probe (green) con-
sisted of 96 oligos that cover the 5kb including gene promoter and tran-
scribed regions. (B) EVA images of EGR1 locus in Jurkat cells showing
DNA methylation in the EGR1 gene. The upper and lower rows show im-
ages of two representative cells. Arrows indicate positions of red foci. Scale
bar 5m. (C) Fraction of cells with both EGR1 foci containing green sig-
nal (di+/+), one of the foci with green signal (mono+/−), and both foci
without green signal (di−/−).
by mitogens. The EGR1 EVA probe covers gene promoter
and transcribed regions (Figure 3A). Without the addition
of 5mC antibody no green signal was detected (not shown),
while in its presence there was signal (Figure 3B), again sug-
gesting that the ratio of green to red signal (G/R) served
as an estimate of the 5mC density per locus. In Jurkat cells,
we discriminated three different cell subpopulations, (i) cells
with both EGR1 foci containing green signal, (ii) cells with
one of the foci with green signal and (iii) cells with both foci
showing no green signal (Figure 3C). These data illustrate
that the methylation status of EGR1 alleles is not uniform
in this specific cell population, which may be explained by
the dynamic nature of DNA methylation at this locus and
by the inefficiency of serum starvation to block cell prolif-
eration in cancer cell lines (40). Treatment of these serum-
starved cells with mitogens, such as serum or TPA, rapidly
activated EGR1 transcription in the majority of cells, as de-
tected by RT-qPCR (Supplemental Figure S2A) and RNA
FISH (Supplemental Figure S2B) (41). Therefore, the RNA
FISH-EVA combined assay can be used to examine kinet-
ics of epigenetic changes at the locus during gene activa-
tion (Supplemental Figure S3). It should be noted that the
EGR1 EVA probe covers both, promoter and gene body re-
gions (Figure 3A), but according to MeDIP analysis (Sup-
plemental Figure S3C), there is little or no methylation
around the promoter region (in accordance with the EGR1
methylation map at http://neomorph.salk.edu). Therefore,
most of EGR1 EVA 5mC (green) signal likely comes from
the 3′ part of the gene body. Shorter EVA probes can be used
in a study focused on gene promoters or other regions.
Figure 4. HIV provirus in latently infected cells. (A) Schematic overview of
the HIV genome and the EVA probe (green bar) that covers 5′ 5kb region
of the HIV-1 genome. In the used cell lines (J-Lat), the ENV gene is mu-
tated (red cross), and the NEF gene is replaced with GFP (green box). (B)
Representative EVA images of the HIV locus in J-Lat 8.4 cell line that con-
tains one copy of the HIV-1 provirus. EVA was done with 5mC antibody
(upper row) or without antibody (lower row). Arrows indicate positions
of red foci. Scale bar, 5 m. (C) Quantitation of DNA methylation levels
of the HIV-1 proviral genome and dynamic range of the HIV EVA signal
measurements. Orange: green-to-red EVA signal ratios of HIV locus with
(5mC Ab)and without 5mC antibody (no Ab). Blue: HIV EVA was done
in the same cells without lambda exonuclease treatment to estimate max-
imum green signal intensity and technical noise. Different proportions of
green oligo were mixed with the same unlabeled oligo (0.00, 0.33, 0.67, 1.00
labeled-to-unlabeled oligo ratios). Each dot represents one cell.
In a fraction of Jurkat cells both EVA and RNA FISH re-
vealed more than two EGR1 foci per nucleus (3 or 4) (Sup-
plemental Figures S2B and S3B). To test the hypothesis that
additional EVA signals were related to DNA replication
during the cell cycle rather than unspecific hybridization, we
used EGR1 RNA FISH staining combined with 5-bromo-
2′-deoxyuridine (BrdU) pulse labeling to detect replicat-
ing (S-phase) Jurkat cells. This revealed that BrdU-positive
cells (thus representing cells in S or G2 phase) had three or
four EGR1 foci, whereas most of the BrdU-negative cells
(representing G1-phase cells) predominantly had only two
foci (Supplemental Figure S2C). These observations sup-
port our suggestion that the number of EGR1 foci reflects
the cell’s DNA replication status. These data also demon-
strate that EVA can be used to monitor the epigenetic status
of genes in different phases of the cell cycle.
HIV provirus EVA
To further explore the utility of EVA, we applied it to
the highly relevant topic of rare event detection, the DNA
methylation of integrated HIV-1 provirus. In these experi-
ments we used J-Lat 8.4 and J-Lat 9.2 cell lines derived from
HIV-1 infected Jurkat cells that were selected to contain one
copy of provirus per genome (29). The HIV EVA probe was
designed to target the 5′ half of the virus (5 kb, Figure 4A).
The HIV RNA FISH probe (48 oligos) was targeting gag
and pol RNA regions. To test if the HIV EVA signal was spe-
cific to the HIV-1 locus, we performed a FISH assay with a
mixture of two hybridization probes, one probe to the HIV
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genome (same as used in EVA) and another BAC clone-
based DNA FISH probe to the genomic region adjacent
to the insertion site (Supplemental Figure S4A). In J-Lat
8.4 cells, HIV-1 is integrated into the FUBP1 gene on chro-
mosome 1, therefore the adjacent BAC clone RP11-156K6
(143 kb) was used. Co-FISH revealed juxtaposition of the
HIV probe focus and one of two BAC DNA FISH foci.
Additionally, none of the J-Lat 9.2 cells, in which the HIV-
1 genome is integrated elsewhere, showed overlap between
the HIV probe and the FUBP-1 BAC FISH probe (Supple-
mental Figure S4B). No HIV genome signal was detected
in uninfected Jurkat cells (not shown), all together support-
ing specificity of the HIV DNA probe used in EVA. This
probe produced measurable 5mC EVA signal at the HIV
locus (Figure 4B) in the majority of cells (>80%).
To estimate the dynamic range of the assay, we performed
an EVA experiment where green detector oligomer was
mixed with unlabeled oligomer in different proportions and
no -exonuclease was used. This approach allowed for es-
timation of the lowest (0%) and highest (100%) possible
G/R values. Average HIV-1 G/R signal intensity measured
by EVA is 87% of the highest G/R that could be obtained
with this probe (Figure 4C). These results indicate that there
is substantial CpG methylation at the HIV locus in J-Lat
8.4 cells, which is consistent with high degree of HIV-1
DNA methylation in this cell line estimated using other ap-
proaches (42). Importantly, this type of analysis also allows
one to estimate the contribution of technical noise to the
cell-to-cell variation in EVA measurements. While the vari-
ation in G/R measured in cells that were treated without
-exonuclease is due to technical noise, in -exonuclease
treated cells such variation is a result of both technical noise
and biological variation. Figure 4C shows indeed that tech-
nical signal variation (coefficient of variation, CV = 0.23.
CV is defined as SD/mean) is lower than HIV-1 5mC EVA
signal variation (CV = 0.35). High 5mC EVA signal varia-
tion at HIV-1 locus is in line with the previously described
cell-to-cell variation in HIV-1 DNA methylation, detected
as a wide diversity of methylation patterns between bisul-
fite sequencing reads (42). Moreover, it is compatible with
the genome-wide cell-to-cell methylation heterogeneity de-
termined by single cell bisulfite sequencing (scBS) approach
(43), where CpG methylation concordance between individ-
ual cells was estimated as ∼70%, and CV of global methy-
lation measurements between individual cells was 0.40 for a
cell culture.
The length of the above-described EVA probes (5 kb) is
not suitable for analysis of shorter genomic regions of inter-
est, such as gene promoters or CGIs. To assess lower limits
of EVA probe size, HIV probes of decreasing length were
tested (Supplemental Figure S5A–C). These experiments
define 1 kb as a lower size limit for the current EVA. A 1
kb probe allows detecting differences in 5mC density along
the first kb of the HIV locus where the LTR harbors higher
density of CpGs, compared to the second kb of the locus
(Supplemental Figure S5D). Shorter probe sizes are associ-
ated with higher noise in signal measurements. In attempt
to reduce the noise, we found that increasing the number of
optical slices decreased the variation in the measurements,
likely by buffering chromatic shifts in the z-axis between red
and green signals (Supplemental Figure S5E).
To assess the ability of EVA to detect quantitative
changes in DNA methylation at a locus induced by experi-
mental treatment of cells known to alter 5mC levels, we used
J-Lat 8.4 cells exposed to DNA methylation inhibitor DAC
(5 uM, 48 h). Such treatment substantially decreased DNA
methylation levels at the HIV 5′ LTR region as revealed by
MeDIP analysis (Supplemental Figure S6, lower panel). In
line with this, EVA revealed a statistically significant de-
crease in G/R for this locus, demonstrating its quantitative
performance.
J-Lat cell lines were selected as cells where integrated
HIV-1 was transcriptionally silenced (29). Various agents,
including TPA, can activate HIV-1 transcription in these
cells (21,42). We used RT-qPCR and RNA FISH to exam-
ine HIV-1 transcription in cells treated with TPA. Unlike
rapid EGR1 activation (Supplemental Figure S3), no HIV-
1 transcription was detected after 30 min of TPA treatment
in J-Lat 8.4 cells. However, after 8 hours of treatment, there
was robust RT-qPCR HIV-1 RNA signal (>100-fold induc-
tion compared to zero time point, data not shown). Yet,
RNA-FISH (for HIV-1 transcripts) and FACS (for GFP)
revealed that only a small fraction of the cell population
(10% and 12.8%, respectfully) expressed HIV locus (Sup-
plemental Figure S7A, B). To link epigenetic changes at
the HIV-1 locus to the transcription status of the provirus,
we combined EVA with RNA FISH. Results of the com-
bined assay (Supplemental Figure S7A) show that we can
detect both, HIV-1 transcript (blue) at the provirus locus
and DNA methylation (green) at the same locus in cells
that transcribe HIV-1. RNA-FISH tyramide signal ampli-
fication (TSA) signal intensity is proportional to the tran-
script levels at the locus (Supplemental Figure S7C), which
enables quantitative analysis of proviral DNA methylation
(promoter or gene body) in relation to its transcription sta-
tus.
Histone modification EVA
For EVA analysis of histone modifications, simple replace-
ment of 5mC antibodies with those that recognize histones
did not work, and several modifications were needed to the
initial implementation of EVA. First, methacarn used for
cell fixation removes histones from cell nuclei, which is why
cells were now fixed in cold 70% ethanol. As shown in Fig-
ure 5, antibodies to H3K9Ac stain cell nuclei in such cells,
and as expected signal intensity increases in cells treated
with the HDAC inhibitor trichostatin A. Second, probe hy-
bridization conditions destroyed histone modification anti-
gens that we tested. Thus, after fixation, cells were incubated
with H3K9Ac antibodies followed by secondary antibody
HRP-conjugate, then TSA reaction was performed to de-
posit biotin groups. After this, the regular EVA protocol
was used with the rDNA probe and anti-biotin antibody
conjugated to AP. EVA analysis revealed differential histone
acetylation, high at some rDNA loci clusters and low at oth-
ers (Figure 5A). Incubation with trichostatin A increased
the relative intensity of H3K9Ac EVA signal at rDNA loci
(Figure 5B, C, and Supplemental Figure S8). These results
demonstrate the potential of EVA approach to study his-
tone modifications.
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Figure 5. Histone modification H3K9Ac EVA analysis of rDNA. (A)
H3K9Ac-EVA assay was done in HEK293 cells, grown on coverslips
and fixed with cold 70% ethanol, incubated with (top row) or without
(bottom row) antibodies. Projections of z-stack images of representative
cells are shown. Scale bar, 5 m. For quantitative measurements, serum-
starved cells were treated with or without HDAC inhibitor trichostatin
A (1 M, overnight). (B) Immunofluorescent staining, shown are projec-
tions of z-stack images of untreated and trichostatin A-treated cells (TSA)
stained with H3K9Ac antibodies (red), and counterstained with DAPI
(blue). Scale bar, 5 m. (C) results of H3K9Ac-EVA image analysis. Green
(H3K9Ac) and red (rDNA) signal intensities were measured, green/red ra-
tios are shown on the graph. P < 0.001 for −TSA and +TSA, n = 25.
Method limitations
In EVA, signal intensity is determined by the probe length
as it defines the number of fluorophore groups. For single
copy genes, we currently use mixtures of 20–96 gene-specific
oligonucleotides. As a result, epigenetic measurements are
averaged for the region covered by EVA probe (1–5 kb), and
detected changes reflect coordinated behavior of all CpGs
present within this region, masking contribution of indi-
vidual CpGs. Narrowing the EVA probes down to single
CpGs will require additional signal amplification, further
improvements in hybridization conditions, and more sensi-
tive microscopy techniques.
For a single copy gene, the EVA signal is amplified using
branched oligos (Supplemental Figure S1). Such amplifica-
tion is associated with increased physical distance between
the epigenetic marks and the sensor oligos, and therefore
decreased resolution. Currently, the signal is amplified 16-
fold, and the estimated size of the branched oligonucleotide
‘tree’ is 25 nm, which is comparable to the size of a complex
between the primary and secondary antibodies, and on the
same scale with 30 nm chromatin fibers. Additional rounds
of EVA signal amplification would allow for further de-
crease of probe size below the current limit of 1 kb, although
it may not be practical and would potentially increase influ-
ence of other genes forming contact domains (e.g. in topo-
logically associated domains). Size of these complexes also
limits the resolution to about 100 bp (considering that DNA
is not folded) or more. Therefore, methylation status of in-
dividual CpGs present in a short segment of DNA currently
cannot be resolved. Instead, EVA estimates synchronous
changes in CpG methylation over regions covered by the
length of the probe.
EVA is designed for analysis of one epigenetic mark at a
time. The same limitation applies to all other available single
cell epigenetic technologies (e.g. scBS). Simultaneous anal-
ysis of several epigenetic marks (e.g. DNA hydroxymethyla-
tion and methylation) by EVA is feasible by using additional
enzyme-substrate pairs, and additional colors.
Our observations (Figures 2C and 4C) suggested that
there is biological contribution to the 5mC signal variation
between cells and between gene alleles in a cell. Although
state-of-the-art single cell bisulfite sequencing approaches
also reveal high cell-to-cell variance in DNA methylation
(43), validation of EVA observations remains a challenge
because it will require isolation and bisulfite sequencing of
individual gene alleles from the same cells that were ex-
amined by EVA, a task which is technically not feasible at
present.
CONCLUSIONS
We have developed EVA, an in situ proximity biochemi-
cal reaction-based method for quantitative analysis of epi-
genetic marks at genes of interest in a single cell. This
method utilizes inexpensive readily available reagents and
standard lab equipment, it is as simple as the conventional
FISH assay, it can be multiplexed, and automated for high-
throughput purposes.
Despite limitations listed above, EVA has several advan-
tages over sequencing-based methods. First, it allows moni-
toring methylation status of individual gene alleles in a cell.
Second, if combined with RNA-FISH, it provides a means
to link changes in gene expression to epigenetic marks in
the same cell. Third, if applied to tissues, such as a devel-
oping embryo or tumor, EVA measurements can be linked
to histological information to advance data interpretation.
Finally, it has been demonstrated that this method can also
be used to visualize other epigenetic modifications (e.g. hi-
stone modifications). The only requirement is a validated
antibody.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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